868395-53-3 Usage
Uses
Used in Organic Synthesis:
3-(6-METHYLPYRIDIN-2-YL)-3-OXOPROPANENITRILE is used as a building block for the synthesis of various organic compounds. Its unique structure and reactivity make it a valuable component in the creation of new molecules with potential applications in various industries.
Used in Pharmaceutical Research:
3-(6-METHYLPYRIDIN-2-YL)-3-OXOPROPANENITRILE is used as a key intermediate in the development of novel drugs. Its diverse reactivity allows for the exploration of different chemical pathways, leading to the discovery of new therapeutic agents with potential benefits in treating various diseases and conditions.
Used in Agrochemical Development:
3-(6-METHYLPYRIDIN-2-YL)-3-OXOPROPANENITRILE is used as a starting material in the synthesis of agrochemicals. Its properties and reactivity contribute to the development of new pesticides, herbicides, and other agricultural chemicals that can improve crop yields and protect plants from pests and diseases.
Used in Chemical Research:
3-(6-METHYLPYRIDIN-2-YL)-3-OXOPROPANENITRILE is used as a subject of study in chemical research. Its unique structure and reactivity provide opportunities for scientists to explore new chemical reactions and mechanisms, potentially leading to advancements in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 868395-53-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,8,3,9 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 868395-53:
(8*8)+(7*6)+(6*8)+(5*3)+(4*9)+(3*5)+(2*5)+(1*3)=233
233 % 10 = 3
So 868395-53-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O/c1-7-3-2-4-8(11-7)9(12)5-6-10/h2-4H,5H2,1H3
868395-53-3Relevant academic research and scientific papers
2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones
-
Page/Page column 11-12, (2010/02/14)
The present invention provides novel 2-pyridinyl[7(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones with at least one substituent on both the 2- and 4-pyridinyl ring having the chemical structure of formula I: The invention further provides compositions and methods employing the novel 2-pyridinyl[7-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones of formula I to modulate GABA and GABAA receptor physiology to elicit therapeutic responses in mammalian subjects to alleviate neurological or psychiatric disorders, including stroke, head trauma, epilepsy, pain, migraine, mood disorders, anxiety, post traumatic stress disorder, obsessive compulsive disorders, mania, bipolar disorders, schizophrenia, seizures, convulsions, tinnitus, neurodegenerative disorders including Alzheimer's disease, amyotrophic lateral sclerosis and Parkinson's disease, Huntington's chorea, depression, bipolar disorders, mania, trigeminal and other neuralgia, neuropathic pain, hypertension, cerebral ischemia, cardiac arrhythmia, myotonia, substance abuse, myoclonus, essential tremor, dyskinesia and other movement disorders, neonatal cerebral hemorrhage, and spasticity, as well as other psychiatric and neurological disorders mediated by GABA and/or GABAA receptors.
